PRESS RELEASE published on 09/12/2024 at 14:03, 1 year 8 months ago Executive Board of Symrise AG reorganized Symrise AG reorganizes Executive Board with Walter Ribeiro appointed for Taste, Nutrition & Health. Jörn Andreas leaves. Jean-Yves Parisot interim head of Scent & Care segment Executive Board Reorganization Symrise AG Walter Ribeiro Jörn Andreas
BRIEF published on 08/01/2024 at 07:35, 1 year 9 months ago Symrise annonce une croissance rentable au premier trimestre 2024 malgré les défis mondiaux Résultats Financiers Croissance Rentable Marge D'EBITDA Symrise AG Croissance Organique Des Ventes
BRIEF published on 08/01/2024 at 07:35, 1 year 9 months ago Symrise Reports Q1 2024 Profitable Growth Despite Global Challenges Financial Results EBITDA Margin Organic Sales Growth Profitable Growth Symrise AG
PRESS RELEASE published on 08/01/2024 at 07:30, 1 year 9 months ago Symrise on a profitable growth course in a challenging environment Symrise AG reports 6.3% sales increase and higher profitability in H1 2024. Targets 5-7% organic growth in 2024 with 20% EBITDA margin Profitability EBITDA Margin Sales Increase Growth Targets Symrise AG
BRIEF published on 04/25/2024 at 07:35, 2 years ago Symrise annonce un bon début d’année 2024 avec de meilleures projections de ventes et de croissance Symrise AG Croissance Organique Des Ventes Croissance Financière 2024 Division Parfums Et Soins Objectifs D'EBITDA
BRIEF published on 04/25/2024 at 07:35, 2 years ago Symrise Reports Strong Start to 2024 with Enhanced Sales and Growth Projections Organic Sales Growth Symrise AG 2024 Financial Growth Scent And Care Division EBITDA Targets
PRESS RELEASE published on 04/25/2024 at 07:30, 2 years ago Symrise sees successful start into the 2024 fiscal year Symrise AG reports successful start in 2024 fiscal year with 10.9% organic growth and €1.3 billion in group sales for Q1. Targets through 2028 confirmed Organic Growth Sales Increase Symrise AG 2024 Fiscal Year Long-term Targets
BRIEF published on 03/06/2024 at 07:35, 2 years 2 months ago Symrise AG annonce une croissance malgré les défis économiques en 2023 Résultats Financiers 2023 Augmentation Du Dividende Symrise AG Transition De Leadership La Croissance Du Marché
BRIEF published on 03/06/2024 at 07:35, 2 years 2 months ago Symrise AG Reports Growth Amid Economic Challenges in 2023 Dividend Increase Leadership Transition Market Growth Financial Results 2023 Symrise AG
PRESS RELEASE published on 03/06/2024 at 07:30, 2 years 2 months ago Symrise AG again raises sales significantly in 2023 Symrise AG reports significant sales increase in 2023 fiscal year, with adjusted EBITDA slightly below previous year. Company plans 14th consecutive dividend increase and reaffirms long-term growth strategy EBITDA Dividend Increase Sales Increase Long-term Growth Symrise AG
Published on 05/22/2026 at 14:04, 8 hours 24 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 8 hours 28 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 8 hours 28 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 8 hours 28 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 22:05, 23 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 23 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 2 hours 37 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 3 hours 55 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 3 hours 58 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 2 hours 53 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 4 hours 22 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 4 hours 22 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 9 hours 35 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 9 hours 35 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
